nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP2C9—brain cancer	0.565	1	CbGaD
Flunitrazepam—UGT1A1—Etoposide—brain cancer	0.074	0.28	CbGbCtD
Flunitrazepam—CYP1A2—Carmustine—brain cancer	0.0566	0.214	CbGbCtD
Flunitrazepam—CYP3A4—Temozolomide—brain cancer	0.0428	0.162	CbGbCtD
Flunitrazepam—CYP3A4—Lomustine—brain cancer	0.0364	0.138	CbGbCtD
Flunitrazepam—CYP2E1—Etoposide—brain cancer	0.029	0.11	CbGbCtD
Flunitrazepam—CYP1A2—Etoposide—brain cancer	0.0168	0.0635	CbGbCtD
Flunitrazepam—Unsteadiness—Procarbazine—brain cancer	0.0105	0.119	CcSEcCtD
Flunitrazepam—CYP3A4—Etoposide—brain cancer	0.00879	0.0333	CbGbCtD
Flunitrazepam—Slurred speech—Procarbazine—brain cancer	0.00471	0.0536	CcSEcCtD
Flunitrazepam—Balance disorder—Procarbazine—brain cancer	0.00385	0.0439	CcSEcCtD
Flunitrazepam—Emotional distress—Hydroxyurea—brain cancer	0.00383	0.0437	CcSEcCtD
Flunitrazepam—Dysarthria—Lomustine—brain cancer	0.0035	0.0399	CcSEcCtD
Flunitrazepam—Disorientation—Lomustine—brain cancer	0.00269	0.0306	CcSEcCtD
Flunitrazepam—Ataxia—Lomustine—brain cancer	0.00226	0.0258	CcSEcCtD
Flunitrazepam—Dysarthria—Procarbazine—brain cancer	0.00222	0.0253	CcSEcCtD
Flunitrazepam—GABRA6—hindbrain—brain cancer	0.00211	0.049	CbGeAlD
Flunitrazepam—Nightmare—Procarbazine—brain cancer	0.00203	0.0232	CcSEcCtD
Flunitrazepam—GABRA2—ganglion—brain cancer	0.00187	0.0435	CbGeAlD
Flunitrazepam—Disorientation—Procarbazine—brain cancer	0.00171	0.0195	CcSEcCtD
Flunitrazepam—Diplopia—Procarbazine—brain cancer	0.00153	0.0174	CcSEcCtD
Flunitrazepam—Ataxia—Procarbazine—brain cancer	0.00144	0.0164	CcSEcCtD
Flunitrazepam—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00143	0.0394	CbGpPWpGaD
Flunitrazepam—GABRA2—hindbrain—brain cancer	0.00142	0.033	CbGeAlD
Flunitrazepam—TSPO—blood vessel—brain cancer	0.00138	0.032	CbGeAlD
Flunitrazepam—GABRA1—hindbrain—brain cancer	0.00137	0.0319	CbGeAlD
Flunitrazepam—UGT2B7—Tamoxifen metabolism—CYP2C9—brain cancer	0.00136	0.0375	CbGpPWpGaD
Flunitrazepam—Disorientation—Hydroxyurea—brain cancer	0.00132	0.0151	CcSEcCtD
Flunitrazepam—UGT1A3—endocrine gland—brain cancer	0.00125	0.0291	CbGeAlD
Flunitrazepam—GABRA6—brainstem—brain cancer	0.00121	0.0281	CbGeAlD
Flunitrazepam—Drowsiness—Procarbazine—brain cancer	0.00118	0.0134	CcSEcCtD
Flunitrazepam—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00115	0.0318	CbGpPWpGaD
Flunitrazepam—Acenocoumarol—CYP2C9—brain cancer	0.00115	0.372	CrCbGaD
Flunitrazepam—UGT1A3—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00114	0.0315	CbGpPWpGaD
Flunitrazepam—Sweating—Procarbazine—brain cancer	0.00113	0.0129	CcSEcCtD
Flunitrazepam—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00113	0.0311	CbGpPWpGaD
Flunitrazepam—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00112	0.031	CbGpPWpGaD
Flunitrazepam—GABRA6—telencephalon—brain cancer	0.00107	0.0249	CbGeAlD
Flunitrazepam—Hallucination—Procarbazine—brain cancer	0.00105	0.012	CcSEcCtD
Flunitrazepam—GABRA5—telencephalon—brain cancer	0.00104	0.0242	CbGeAlD
Flunitrazepam—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00102	0.0282	CbGpPWpGaD
Flunitrazepam—Amnesia—Carmustine—brain cancer	0.00102	0.0116	CcSEcCtD
Flunitrazepam—Amnesia—Temozolomide—brain cancer	0.000983	0.0112	CcSEcCtD
Flunitrazepam—Diplopia—Carmustine—brain cancer	0.000956	0.0109	CcSEcCtD
Flunitrazepam—GABRA4—telencephalon—brain cancer	0.000946	0.0219	CbGeAlD
Flunitrazepam—Diplopia—Temozolomide—brain cancer	0.000923	0.0105	CcSEcCtD
Flunitrazepam—Drowsiness—Hydroxyurea—brain cancer	0.000911	0.0104	CcSEcCtD
Flunitrazepam—Ataxia—Carmustine—brain cancer	0.000899	0.0102	CcSEcCtD
Flunitrazepam—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.000884	0.0244	CbGpPWpGaD
Flunitrazepam—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000875	0.0241	CbGpPWpGaD
Flunitrazepam—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00087	0.024	CbGpPWpGaD
Flunitrazepam—Ataxia—Temozolomide—brain cancer	0.000868	0.00989	CcSEcCtD
Flunitrazepam—Tremor—Procarbazine—brain cancer	0.000862	0.00982	CcSEcCtD
Flunitrazepam—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000851	0.0235	CbGpPWpGaD
Flunitrazepam—Muscular weakness—Carmustine—brain cancer	0.000843	0.0096	CcSEcCtD
Flunitrazepam—GABRA2—brainstem—brain cancer	0.000814	0.0189	CbGeAlD
Flunitrazepam—Muscular weakness—Temozolomide—brain cancer	0.000814	0.00928	CcSEcCtD
Flunitrazepam—Hallucination—Hydroxyurea—brain cancer	0.000814	0.00927	CcSEcCtD
Flunitrazepam—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000796	0.022	CbGpPWpGaD
Flunitrazepam—UGT1A1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000788	0.0217	CbGpPWpGaD
Flunitrazepam—GABRA1—brainstem—brain cancer	0.000787	0.0183	CbGeAlD
Flunitrazepam—Anxiety—Procarbazine—brain cancer	0.00078	0.00889	CcSEcCtD
Flunitrazepam—GABRA4—pituitary gland—brain cancer	0.00077	0.0179	CbGeAlD
Flunitrazepam—Dry mouth—Procarbazine—brain cancer	0.000766	0.00873	CcSEcCtD
Flunitrazepam—Confusional state—Procarbazine—brain cancer	0.000757	0.00863	CcSEcCtD
Flunitrazepam—TSPO—brainstem—brain cancer	0.000754	0.0175	CbGeAlD
Flunitrazepam—Tachycardia—Procarbazine—brain cancer	0.000733	0.00835	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Procarbazine—brain cancer	0.000726	0.00827	CcSEcCtD
Flunitrazepam—GABRA2—telencephalon—brain cancer	0.000723	0.0168	CbGeAlD
Flunitrazepam—UGT2B7—endocrine gland—brain cancer	0.00072	0.0167	CbGeAlD
Flunitrazepam—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000714	0.0197	CbGpPWpGaD
Flunitrazepam—Hypotension—Procarbazine—brain cancer	0.000701	0.00799	CcSEcCtD
Flunitrazepam—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000699	0.0193	CbGpPWpGaD
Flunitrazepam—GABRA1—telencephalon—brain cancer	0.000699	0.0162	CbGeAlD
Flunitrazepam—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000672	0.0186	CbGpPWpGaD
Flunitrazepam—GABRA6—head—brain cancer	0.000669	0.0155	CbGeAlD
Flunitrazepam—TSPO—telencephalon—brain cancer	0.000669	0.0155	CbGeAlD
Flunitrazepam—Somnolence—Procarbazine—brain cancer	0.000667	0.0076	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Hydroxyurea—brain cancer	0.000661	0.00753	CcSEcCtD
Flunitrazepam—Hallucination—Carmustine—brain cancer	0.000658	0.0075	CcSEcCtD
Flunitrazepam—GABRA5—head—brain cancer	0.000649	0.0151	CbGeAlD
Flunitrazepam—Fatigue—Procarbazine—brain cancer	0.000647	0.00738	CcSEcCtD
Flunitrazepam—Malaise—Hydroxyurea—brain cancer	0.000642	0.00732	CcSEcCtD
Flunitrazepam—Hallucination—Temozolomide—brain cancer	0.000636	0.00724	CcSEcCtD
Flunitrazepam—Feeling abnormal—Procarbazine—brain cancer	0.000619	0.00705	CcSEcCtD
Flunitrazepam—GABRA3—endocrine gland—brain cancer	0.000612	0.0142	CbGeAlD
Flunitrazepam—UGT1A1—endocrine gland—brain cancer	0.000612	0.0142	CbGeAlD
Flunitrazepam—GABRA6—central nervous system—brain cancer	0.000611	0.0142	CbGeAlD
Flunitrazepam—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000607	0.0168	CbGpPWpGaD
Flunitrazepam—GABRA3—head—brain cancer	0.000604	0.014	CbGeAlD
Flunitrazepam—Discomfort—Hydroxyurea—brain cancer	0.000599	0.00682	CcSEcCtD
Flunitrazepam—GABRA6—cerebellum—brain cancer	0.000597	0.0138	CbGeAlD
Flunitrazepam—GABRA5—central nervous system—brain cancer	0.000593	0.0137	CbGeAlD
Flunitrazepam—GABRA4—head—brain cancer	0.000589	0.0137	CbGeAlD
Flunitrazepam—TSPO—gonad—brain cancer	0.000558	0.013	CbGeAlD
Flunitrazepam—GABRA3—central nervous system—brain cancer	0.000552	0.0128	CbGeAlD
Flunitrazepam—GABRA1—medulla oblongata—brain cancer	0.000549	0.0127	CbGeAlD
Flunitrazepam—TSPO—pituitary gland—brain cancer	0.000545	0.0126	CbGeAlD
Flunitrazepam—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000539	0.0149	CbGpPWpGaD
Flunitrazepam—Tremor—Carmustine—brain cancer	0.000539	0.00614	CcSEcCtD
Flunitrazepam—Asthenia—Procarbazine—brain cancer	0.000539	0.00614	CcSEcCtD
Flunitrazepam—GABRA4—central nervous system—brain cancer	0.000538	0.0125	CbGeAlD
Flunitrazepam—Agitation—Carmustine—brain cancer	0.000529	0.00603	CcSEcCtD
Flunitrazepam—TSPO—medulla oblongata—brain cancer	0.000526	0.0122	CbGeAlD
Flunitrazepam—GABRA4—cerebellum—brain cancer	0.000525	0.0122	CbGeAlD
Flunitrazepam—Tremor—Temozolomide—brain cancer	0.000521	0.00594	CcSEcCtD
Flunitrazepam—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000519	0.0143	CbGpPWpGaD
Flunitrazepam—Somnolence—Hydroxyurea—brain cancer	0.000516	0.00589	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Temozolomide—brain cancer	0.000516	0.00588	CcSEcCtD
Flunitrazepam—Agitation—Temozolomide—brain cancer	0.000511	0.00582	CcSEcCtD
Flunitrazepam—Angioedema—Temozolomide—brain cancer	0.000508	0.00579	CcSEcCtD
Flunitrazepam—GABRA1—midbrain—brain cancer	0.000502	0.0116	CbGeAlD
Flunitrazepam—Malaise—Temozolomide—brain cancer	0.000502	0.00571	CcSEcCtD
Flunitrazepam—Fatigue—Hydroxyurea—brain cancer	0.000501	0.00571	CcSEcCtD
Flunitrazepam—Dizziness—Procarbazine—brain cancer	0.000496	0.00566	CcSEcCtD
Flunitrazepam—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00049	0.0135	CbGpPWpGaD
Flunitrazepam—GABRA1—spinal cord—brain cancer	0.000489	0.0114	CbGeAlD
Flunitrazepam—Anxiety—Carmustine—brain cancer	0.000488	0.00556	CcSEcCtD
Flunitrazepam—Alprazolam—CYP2C9—brain cancer	0.000487	0.157	CrCbGaD
Flunitrazepam—GABRA6—brain—brain cancer	0.000485	0.0112	CbGeAlD
Flunitrazepam—TSPO—midbrain—brain cancer	0.000481	0.0111	CbGeAlD
Flunitrazepam—Feeling abnormal—Hydroxyurea—brain cancer	0.000479	0.00546	CcSEcCtD
Flunitrazepam—Confusional state—Carmustine—brain cancer	0.000474	0.0054	CcSEcCtD
Flunitrazepam—Rash—Procarbazine—brain cancer	0.000473	0.00539	CcSEcCtD
Flunitrazepam—Dermatitis—Procarbazine—brain cancer	0.000473	0.00539	CcSEcCtD
Flunitrazepam—Quazepam—CYP2C9—brain cancer	0.000473	0.153	CrCbGaD
Flunitrazepam—Anxiety—Temozolomide—brain cancer	0.000472	0.00538	CcSEcCtD
Flunitrazepam—GABRA5—brain—brain cancer	0.00047	0.0109	CbGeAlD
Flunitrazepam—Headache—Procarbazine—brain cancer	0.00047	0.00536	CcSEcCtD
Flunitrazepam—GABRA6—Orphan transporters—S100A10—brain cancer	0.000469	0.0129	CbGpPWpGaD
Flunitrazepam—TSPO—spinal cord—brain cancer	0.000469	0.0109	CbGeAlD
Flunitrazepam—Discomfort—Temozolomide—brain cancer	0.000468	0.00533	CcSEcCtD
Flunitrazepam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000467	0.0129	CbGpPWpGaD
Flunitrazepam—GABRA4—Orphan transporters—S100A10—brain cancer	0.000463	0.0128	CbGpPWpGaD
Flunitrazepam—Dry mouth—Temozolomide—brain cancer	0.000463	0.00528	CcSEcCtD
Flunitrazepam—Tachycardia—Carmustine—brain cancer	0.000458	0.00522	CcSEcCtD
Flunitrazepam—Confusional state—Temozolomide—brain cancer	0.000458	0.00522	CcSEcCtD
Flunitrazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000457	0.0126	CbGpPWpGaD
Flunitrazepam—CYP2A6—cerebellum—brain cancer	0.000454	0.0105	CbGeAlD
Flunitrazepam—GABRA2—head—brain cancer	0.00045	0.0104	CbGeAlD
Flunitrazepam—Hypotension—Carmustine—brain cancer	0.000439	0.005	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Temozolomide—brain cancer	0.000439	0.005	CcSEcCtD
Flunitrazepam—GABRA3—brain—brain cancer	0.000438	0.0102	CbGeAlD
Flunitrazepam—GABRA1—head—brain cancer	0.000435	0.0101	CbGeAlD
Flunitrazepam—GABRA4—brain—brain cancer	0.000427	0.0099	CbGeAlD
Flunitrazepam—TSPO—endocrine gland—brain cancer	0.000422	0.00979	CbGeAlD
Flunitrazepam—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00042	0.0116	CbGpPWpGaD
Flunitrazepam—Somnolence—Carmustine—brain cancer	0.000418	0.00476	CcSEcCtD
Flunitrazepam—Asthenia—Hydroxyurea—brain cancer	0.000417	0.00475	CcSEcCtD
Flunitrazepam—TSPO—head—brain cancer	0.000417	0.00966	CbGeAlD
Flunitrazepam—Ill-defined disorder—Etoposide—brain cancer	0.000413	0.00471	CcSEcCtD
Flunitrazepam—GABRA5—Orphan transporters—S100A10—brain cancer	0.000412	0.0114	CbGpPWpGaD
Flunitrazepam—GABRA2—central nervous system—brain cancer	0.000411	0.00953	CbGeAlD
Flunitrazepam—UGT1A1—Irinotecan Pathway—APC—brain cancer	0.000405	0.0112	CbGpPWpGaD
Flunitrazepam—GABRA3—Orphan transporters—S100A10—brain cancer	0.000404	0.0112	CbGpPWpGaD
Flunitrazepam—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000404	0.0112	CbGpPWpGaD
Flunitrazepam—Somnolence—Temozolomide—brain cancer	0.000403	0.0046	CcSEcCtD
Flunitrazepam—GABRA2—cerebellum—brain cancer	0.000402	0.00931	CbGeAlD
Flunitrazepam—Malaise—Etoposide—brain cancer	0.000401	0.00457	CcSEcCtD
Flunitrazepam—GABRA2—Orphan transporters—S100A10—brain cancer	0.000397	0.011	CbGpPWpGaD
Flunitrazepam—GABRA1—central nervous system—brain cancer	0.000397	0.00921	CbGeAlD
Flunitrazepam—Fatigue—Temozolomide—brain cancer	0.000391	0.00446	CcSEcCtD
Flunitrazepam—GABRA1—cerebellum—brain cancer	0.000388	0.009	CbGeAlD
Flunitrazepam—Feeling abnormal—Carmustine—brain cancer	0.000387	0.00441	CcSEcCtD
Flunitrazepam—CYP2E1—telencephalon—brain cancer	0.000387	0.00896	CbGeAlD
Flunitrazepam—Dizziness—Hydroxyurea—brain cancer	0.000384	0.00438	CcSEcCtD
Flunitrazepam—TSPO—central nervous system—brain cancer	0.00038	0.00882	CbGeAlD
Flunitrazepam—Discomfort—Etoposide—brain cancer	0.000374	0.00427	CcSEcCtD
Flunitrazepam—Feeling abnormal—Temozolomide—brain cancer	0.000374	0.00426	CcSEcCtD
Flunitrazepam—TSPO—cerebellum—brain cancer	0.000372	0.00862	CbGeAlD
Flunitrazepam—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00037	0.0102	CbGpPWpGaD
Flunitrazepam—CYP2A6—brain—brain cancer	0.000369	0.00856	CbGeAlD
Flunitrazepam—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000367	0.0101	CbGpPWpGaD
Flunitrazepam—Rash—Hydroxyurea—brain cancer	0.000366	0.00417	CcSEcCtD
Flunitrazepam—Confusional state—Etoposide—brain cancer	0.000366	0.00417	CcSEcCtD
Flunitrazepam—Dermatitis—Hydroxyurea—brain cancer	0.000366	0.00417	CcSEcCtD
Flunitrazepam—Headache—Hydroxyurea—brain cancer	0.000364	0.00415	CcSEcCtD
Flunitrazepam—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000362	0.01	CbGpPWpGaD
Flunitrazepam—Triazolam—CYP2C9—brain cancer	0.000358	0.116	CrCbGaD
Flunitrazepam—Tachycardia—Etoposide—brain cancer	0.000354	0.00404	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Etoposide—brain cancer	0.000351	0.004	CcSEcCtD
Flunitrazepam—CYP2B6—gonad—brain cancer	0.000344	0.00797	CbGeAlD
Flunitrazepam—Temazepam—CYP2C9—brain cancer	0.000342	0.111	CrCbGaD
Flunitrazepam—Hypotension—Etoposide—brain cancer	0.000339	0.00387	CcSEcCtD
Flunitrazepam—GABRA1—Orphan transporters—S100A10—brain cancer	0.000339	0.00935	CbGpPWpGaD
Flunitrazepam—Asthenia—Carmustine—brain cancer	0.000337	0.00384	CcSEcCtD
Flunitrazepam—CYP2C19—endocrine gland—brain cancer	0.000332	0.0077	CbGeAlD
Flunitrazepam—GABRA2—brain—brain cancer	0.000326	0.00756	CbGeAlD
Flunitrazepam—Asthenia—Temozolomide—brain cancer	0.000326	0.00371	CcSEcCtD
Flunitrazepam—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000324	0.00895	CbGpPWpGaD
Flunitrazepam—Somnolence—Etoposide—brain cancer	0.000323	0.00368	CcSEcCtD
Flunitrazepam—GABRA1—brain—brain cancer	0.000315	0.00731	CbGeAlD
Flunitrazepam—Fatigue—Etoposide—brain cancer	0.000313	0.00357	CcSEcCtD
Flunitrazepam—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000312	0.00861	CbGpPWpGaD
Flunitrazepam—Dizziness—Carmustine—brain cancer	0.000311	0.00354	CcSEcCtD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000306	0.00845	CbGpPWpGaD
Flunitrazepam—CYP2E1—medulla oblongata—brain cancer	0.000304	0.00704	CbGeAlD
Flunitrazepam—TSPO—brain—brain cancer	0.000302	0.007	CbGeAlD
Flunitrazepam—Dizziness—Temozolomide—brain cancer	0.0003	0.00342	CcSEcCtD
Flunitrazepam—Feeling abnormal—Etoposide—brain cancer	0.000299	0.00341	CcSEcCtD
Flunitrazepam—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000298	0.00822	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—CYP2C9—brain cancer	0.000297	0.00819	CbGpPWpGaD
Flunitrazepam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000296	0.00818	CbGpPWpGaD
Flunitrazepam—Rash—Carmustine—brain cancer	0.000296	0.00337	CcSEcCtD
Flunitrazepam—Dermatitis—Carmustine—brain cancer	0.000296	0.00337	CcSEcCtD
Flunitrazepam—Headache—Carmustine—brain cancer	0.000294	0.00335	CcSEcCtD
Flunitrazepam—UGT1A3—Metapathway biotransformation—CYP2C9—brain cancer	0.000293	0.00808	CbGpPWpGaD
Flunitrazepam—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000292	0.00807	CbGpPWpGaD
Flunitrazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00029	0.00801	CbGpPWpGaD
Flunitrazepam—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000286	0.0079	CbGpPWpGaD
Flunitrazepam—Rash—Temozolomide—brain cancer	0.000286	0.00326	CcSEcCtD
Flunitrazepam—Dermatitis—Temozolomide—brain cancer	0.000286	0.00326	CcSEcCtD
Flunitrazepam—Diazepam—CYP2C9—brain cancer	0.000285	0.0919	CrCbGaD
Flunitrazepam—Headache—Temozolomide—brain cancer	0.000284	0.00324	CcSEcCtD
Flunitrazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000275	0.00758	CbGpPWpGaD
Flunitrazepam—CYP1A2—endocrine gland—brain cancer	0.000271	0.00629	CbGeAlD
Flunitrazepam—CYP2E1—spinal cord—brain cancer	0.000271	0.00628	CbGeAlD
Flunitrazepam—Asthenia—Etoposide—brain cancer	0.000261	0.00297	CcSEcCtD
Flunitrazepam—CYP2B6—endocrine gland—brain cancer	0.00026	0.00603	CbGeAlD
Flunitrazepam—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000259	0.00715	CbGpPWpGaD
Flunitrazepam—CYP2C9—endocrine gland—brain cancer	0.000257	0.00597	CbGeAlD
Flunitrazepam—CYP2B6—head—brain cancer	0.000256	0.00595	CbGeAlD
Flunitrazepam—UGT2B7—Biological oxidations—CYP2C9—brain cancer	0.000252	0.00697	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metapathway biotransformation—CYP2C9—brain cancer	0.000249	0.00687	CbGpPWpGaD
Flunitrazepam—CYP2E1—endocrine gland—brain cancer	0.000244	0.00565	CbGeAlD
Flunitrazepam—CYP2E1—head—brain cancer	0.000241	0.00558	CbGeAlD
Flunitrazepam—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00024	0.00663	CbGpPWpGaD
Flunitrazepam—Dizziness—Etoposide—brain cancer	0.00024	0.00274	CcSEcCtD
Flunitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000235	0.00649	CbGpPWpGaD
Flunitrazepam—CYP2B6—central nervous system—brain cancer	0.000234	0.00543	CbGeAlD
Flunitrazepam—Rash—Etoposide—brain cancer	0.000229	0.00261	CcSEcCtD
Flunitrazepam—Dermatitis—Etoposide—brain cancer	0.000229	0.00261	CcSEcCtD
Flunitrazepam—Headache—Etoposide—brain cancer	0.000228	0.00259	CcSEcCtD
Flunitrazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000224	0.00618	CbGpPWpGaD
Flunitrazepam—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000223	0.00614	CbGpPWpGaD
Flunitrazepam—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000221	0.0061	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—HES5—brain cancer	0.00022	0.00608	CbGpPWpGaD
Flunitrazepam—CYP2E1—central nervous system—brain cancer	0.00022	0.0051	CbGeAlD
Flunitrazepam—CYP2E1—cerebellum—brain cancer	0.000215	0.00498	CbGeAlD
Flunitrazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000212	0.00585	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000212	0.00584	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—CYP2C9—brain cancer	0.000205	0.00566	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000202	0.00558	CbGpPWpGaD
Flunitrazepam—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000202	0.00557	CbGpPWpGaD
Flunitrazepam—CYP3A4—endocrine gland—brain cancer	0.000196	0.00455	CbGeAlD
Flunitrazepam—CYP2B6—brain—brain cancer	0.000186	0.00431	CbGeAlD
Flunitrazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000182	0.00501	CbGpPWpGaD
Flunitrazepam—CYP3A4—central nervous system—brain cancer	0.000177	0.0041	CbGeAlD
Flunitrazepam—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000174	0.00482	CbGpPWpGaD
Flunitrazepam—CYP2E1—brain—brain cancer	0.000174	0.00405	CbGeAlD
Flunitrazepam—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000172	0.00475	CbGpPWpGaD
Flunitrazepam—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000168	0.00463	CbGpPWpGaD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000159	0.00439	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000158	0.00436	CbGpPWpGaD
Flunitrazepam—GABRA6—Ion channel transport—TRPC6—brain cancer	0.000152	0.00419	CbGpPWpGaD
Flunitrazepam—GABRA4—Ion channel transport—TRPC6—brain cancer	0.00015	0.00414	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000141	0.0039	CbGpPWpGaD
Flunitrazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000135	0.00372	CbGpPWpGaD
Flunitrazepam—GABRA5—Ion channel transport—TRPC6—brain cancer	0.000133	0.00368	CbGpPWpGaD
Flunitrazepam—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000133	0.00367	CbGpPWpGaD
Flunitrazepam—GABRA3—Ion channel transport—TRPC6—brain cancer	0.000131	0.00361	CbGpPWpGaD
Flunitrazepam—GABRA2—Ion channel transport—TRPC6—brain cancer	0.000129	0.00355	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000128	0.00352	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000126	0.00347	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000125	0.00345	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000123	0.0034	CbGpPWpGaD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000122	0.00336	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000115	0.00316	CbGpPWpGaD
Flunitrazepam—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000114	0.00316	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—S100A10—brain cancer	0.000113	0.00312	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.00011	0.00303	CbGpPWpGaD
Flunitrazepam—GABRA1—Ion channel transport—TRPC6—brain cancer	0.00011	0.00303	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000109	0.00301	CbGpPWpGaD
Flunitrazepam—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000101	0.0028	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—S100A10—brain cancer	0.0001	0.00277	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—S100A10—brain cancer	9.87e-05	0.00272	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—S100A10—brain cancer	9.7e-05	0.00268	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—CYP2C9—brain cancer	9.64e-05	0.00266	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	9.51e-05	0.00262	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—ESR2—brain cancer	9.38e-05	0.00259	CbGpPWpGaD
Flunitrazepam—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	9.31e-05	0.00257	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	8.41e-05	0.00232	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—S100A10—brain cancer	8.27e-05	0.00228	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	7.75e-05	0.00214	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—CYP2C9—brain cancer	7.51e-05	0.00207	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	7.41e-05	0.00204	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—HES1—brain cancer	7.29e-05	0.00201	CbGpPWpGaD
Flunitrazepam—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	7.1e-05	0.00196	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.8e-05	0.0016	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.72e-05	0.00158	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—TRPC6—brain cancer	5.29e-05	0.00146	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—TRPC6—brain cancer	5.22e-05	0.00144	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CYP2C9—brain cancer	5.08e-05	0.0014	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—TRPC6—brain cancer	4.64e-05	0.00128	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—TRPC6—brain cancer	4.56e-05	0.00126	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.48e-05	0.00124	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.47e-05	0.00123	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP2C9—brain cancer	4.32e-05	0.00119	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—BSG—brain cancer	4.32e-05	0.00119	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.03e-05	0.00111	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.82e-05	0.00105	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—IDH1—brain cancer	3.71e-05	0.00102	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.7e-05	0.00102	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—BSG—brain cancer	3.67e-05	0.00101	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.65e-05	0.00101	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP2C9—brain cancer	3.51e-05	0.000968	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.42e-05	0.000944	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.22e-05	0.000888	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—IDH1—brain cancer	3.16e-05	0.000871	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.15e-05	0.000869	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.08e-05	0.00085	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.08e-05	0.00085	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—BSG—brain cancer	2.98e-05	0.000823	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ENO2—brain cancer	2.93e-05	0.00081	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.89e-05	0.000796	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.71e-05	0.000747	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP2C9—brain cancer	2.7e-05	0.000746	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—IDH1—brain cancer	2.57e-05	0.000708	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ENO2—brain cancer	2.5e-05	0.000689	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.47e-05	0.000681	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—BSG—brain cancer	2.3e-05	0.000635	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP2C9—brain cancer	2.18e-05	0.000602	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP2C9—brain cancer	2.14e-05	0.00059	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.11e-05	0.000582	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ENO2—brain cancer	2.03e-05	0.00056	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—IDH1—brain cancer	1.98e-05	0.000546	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—BSG—brain cancer	1.86e-05	0.000512	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—BSG—brain cancer	1.82e-05	0.000502	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP2C9—brain cancer	1.65e-05	0.000455	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—IDH1—brain cancer	1.6e-05	0.00044	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ENO2—brain cancer	1.56e-05	0.000431	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—IDH1—brain cancer	1.56e-05	0.000431	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—BSG—brain cancer	1.4e-05	0.000387	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CG—brain cancer	1.35e-05	0.000372	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP2C9—brain cancer	1.28e-05	0.000355	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—BSG—brain cancer	1.28e-05	0.000353	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ENO2—brain cancer	1.26e-05	0.000348	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ENO2—brain cancer	1.24e-05	0.000341	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—IDH1—brain cancer	1.21e-05	0.000333	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CG—brain cancer	1.14e-05	0.000316	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—IDH1—brain cancer	1.1e-05	0.000303	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—BSG—brain cancer	1.09e-05	0.000302	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2C9—brain cancer	9.92e-06	0.000274	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.82e-06	0.000271	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ENO2—brain cancer	9.53e-06	0.000263	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—IDH1—brain cancer	9.39e-06	0.000259	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CG—brain cancer	9.3e-06	0.000257	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.95e-06	0.000247	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ENO2—brain cancer	8.69e-06	0.00024	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—BSG—brain cancer	8.43e-06	0.000233	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.65e-06	0.000211	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ENO2—brain cancer	7.43e-06	0.000205	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—IDH1—brain cancer	7.25e-06	0.0002	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CG—brain cancer	7.17e-06	0.000198	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CG—brain cancer	5.79e-06	0.00016	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ENO2—brain cancer	5.73e-06	0.000158	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CG—brain cancer	5.67e-06	0.000156	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CG—brain cancer	4.37e-06	0.000121	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CG—brain cancer	3.99e-06	0.00011	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CG—brain cancer	3.41e-06	9.4e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CG—brain cancer	2.63e-06	7.26e-05	CbGpPWpGaD
